Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ITEM Group is an Italian medical technology company specializing in the development and manufacturing of advanced hyperthermia systems for oncology. The company's flagship ALBA platform provides deep and superficial hyperthermia treatments designed to enhance the efficacy of radiotherapy and chemotherapy. By utilizing non-ionizing electromagnetic radiation to heat tumor tissues, ITEM Group's technology aims to improve clinical outcomes for patients with various solid tumors, including bladder, breast, and soft tissue sarcomas. The company is a leader in the European hyperthermia market, providing both hardware and clinical support to oncology centers. Headquartered in Italy, ITEM Group maintains strong collaborations with leading academic and clinical institutions to advance the field of thermal oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on I.T.E.M. group.